News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
44,880 Results
Type
Article (3556)
Company Profile (26)
Press Release (41298)
Section
Business (14168)
Career Advice (58)
Deals (1814)
Drug Delivery (7)
Drug Development (3732)
Employer Resources (5)
FDA (584)
Job Trends (1274)
News (19957)
Policy (1332)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
Academia (427)
Allergies (4)
Alliances (5596)
ALS (7)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (2)
Approvals (586)
Artificial intelligence (32)
Autoimmune disease (1)
Automation (6)
Bankruptcy (15)
Best Places to Work (1124)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (24)
Bladder cancer (7)
Brain cancer (3)
Breast cancer (44)
Cancer (254)
Cardiovascular disease (8)
Career advice (58)
Career pathing (1)
CAR-T (8)
Cell therapy (44)
Cervical cancer (1)
Clinical research (2618)
Collaboration (113)
Compensation (20)
Complete response letters (1)
COVID-19 (197)
CRISPR (17)
C-suite (14)
Cystic fibrosis (7)
Data (176)
Diabetes (13)
Diagnostics (1398)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (10)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (3394)
Editorial (1)
Employer branding (2)
Employer resources (4)
Events (6382)
Executive appointments (67)
FDA (636)
Featured Employer (5)
Funding (48)
Gene editing (48)
Generative AI (2)
Gene therapy (46)
GLP-1 (33)
Government (292)
Guidances (5)
Healthcare (1231)
Huntington's disease (1)
Immunology and inflammation (3)
Infectious disease (207)
Inflammatory bowel disease (11)
Influenza (5)
Intellectual property (8)
Interviews (5)
IPO (778)
Job creations (185)
Job search strategy (55)
Layoffs (17)
Legal (204)
Liver cancer (7)
Lung cancer (43)
Lymphoma (10)
Machine learning (1)
Management (1)
Manufacturing (26)
MASH (1)
Medical device (415)
Medtech (416)
Mergers & acquisitions (1071)
Metabolic disorders (20)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (83)
NextGen: Class of 2025 (381)
Non-profit (293)
Northern California (249)
Now hiring (2)
Obesity (5)
Opinion (26)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (10)
Parkinson's disease (8)
Partnered (1)
Patents (10)
Patient recruitment (3)
Peanut (1)
People (4488)
Pharmaceutical (2)
Phase I (1157)
Phase II (1234)
Phase III (814)
Pipeline (62)
Policy (15)
Postmarket research (39)
Preclinical (635)
Press Release (22)
Prostate cancer (9)
Radiopharmaceuticals (3)
Rare diseases (37)
Real estate (356)
Recruiting (1)
Regulatory (951)
Reports (3)
Research institute (510)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (1)
Series A (11)
Series B (5)
Sickle cell disease (14)
Southern California (223)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (359)
Supply chain (5)
United States (1718)
Vaccines (22)
Venture capitalists (2)
Weight loss (4)
Date
Last 7 days (40)
Last 30 days (157)
Last 365 days (2656)
2025 (588)
2024 (2844)
2023 (3318)
2022 (4410)
2021 (4610)
2020 (3903)
2019 (2985)
2018 (2214)
2017 (2526)
2016 (2422)
2015 (2482)
2014 (1606)
2013 (1389)
2012 (1419)
2011 (1406)
2010 (1239)
Location
Africa (57)
Alabama (8)
Alaska (1)
Arizona (23)
Asia (2243)
Australia (356)
California (582)
Canada (81)
China (42)
Colorado (16)
Connecticut (30)
Delaware (4)
Europe (5702)
Florida (56)
Georgia (4)
Idaho (2)
Illinois (22)
India (3)
Indiana (10)
Iowa (3)
Japan (17)
Kansas (2)
Kentucky (1)
Louisiana (1)
Maine (3)
Maryland (59)
Massachusetts (344)
Michigan (13)
Minnesota (18)
Missouri (6)
Montana (2)
Nebraska (5)
Nevada (5)
New Hampshire (2)
New Jersey (86)
New Mexico (11)
New York (76)
North Carolina (119)
North Dakota (6)
Northern California (249)
Ohio (18)
Oregon (1)
Pennsylvania (63)
Rhode Island (3)
South America (60)
South Carolina (2)
Southern California (223)
Tennessee (4)
Texas (89)
Utah (22)
Virginia (5)
Washington D.C. (4)
Washington State (35)
Wisconsin (8)
44,880 Results for "paragon genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
January 28, 2025
·
13 min read
Drug Development
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and Ireland
July 10, 2024
·
4 min read
Press Releases
Paragon Therapeutics Appoints Susanna High as Chief Executive Officer
November 21, 2024
·
3 min read
Deals
Elevance Health Announces Closing of Paragon Healthcare Acquisition
Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
March 11, 2024
·
6 min read
BioMidwest
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.
May 2, 2024
·
1 min read
Deals
Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases
Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.
April 3, 2024
·
3 min read
Business
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.
May 8, 2024
·
12 min read
Deals
Elevance Health to Acquire Paragon Healthcare
Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.
January 4, 2024
·
7 min read
Biotech Beach
Paragon Genomics Partners with Devyser to Expand CleanPlex® Technology Distribution in Italy
Paragon Genomics announced a partnership with Devyser, a world leader in diagnostic kits and solutions for advanced DNA testing, to distribute its CleanPlex® products and technology in Italy, with the option to expand into additional territories.
March 1, 2023
·
3 min read
BioMidwest
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Paragon 28, Inc., is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains.
March 28, 2024
·
5 min read
1 of 4,488
Next
